-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vh/ED3f6xGJ1oKBhpiLdO+sWsMB4Lwx4/YapmB56GPxlr9yjjbA/K3hnV7Ucyp0J HAgxsC7QhVw0S1Hm3rPjuQ== 0001125941-09-000007.txt : 20090928 0001125941-09-000007.hdr.sgml : 20090928 20090928162534 ACCESSION NUMBER: 0001125941-09-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090928 DATE AS OF CHANGE: 20090928 EFFECTIVENESS DATE: 20090928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CALYPSO MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0001125941 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-72616 FILM NUMBER: 091090477 BUSINESS ADDRESS: STREET 1: 4TH & BLANCHARD BUILDING STREET 2: 2101 FOURTH AVENUE, SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-254-0600 MAIL ADDRESS: STREET 1: 4TH & BLANCHARD BUILDING STREET 2: 2101 FOURTH AVENUE, SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0603 D LIVE 0001125941 CALYPSO MEDICAL TECHNOLOGIES INC 4TH & BLANCHARD BUILDING 2101 FOURTH AVENUE, SUITE 500 SEATTLE WA 98121 206-254-0600 DELAWARE Calamari Medical, Inc. None Corporation true Eric Meier 4th & Blanchard Building 2101 4th Avenue, Suite 500 Seattle WA 98121 Executive Officer Director John Freund 525 University Avenue, Suite 520 Palo Alto CA 94301 Director Jeanne Cunicelli 750 Battery Street, Suite 400 San Francisco CA 94111 Director Alan Levy 601 Union Street, Suite 3200 Seattle WA 98101 Director Ross Jaffe 3000 Sand Hill Road, Bldg. 1, Suite 260 Menlo Park CA 94025 Director Trever Moody 601 Union Street, Suite 3200 Seattle WA 98101 Director David Gill c/o 4th & Blanchard Building 2101 4th Avenue, Suite 500 Seattle WA 98121 Director Michael Sweeney 2710 Sand Hill Road, Second Floor Menlo Park CA 94025 Director Other Health Care Decline to Disclose 06 false 2009-09-15 false true true false 0 Leerink Swann LLC 39011 Leerink Swann LLC 39011 1 Federal Street 37th Floor Boston MA 02110 CA CT IL MD MA MN NY TX UT WA 51830895 48363045 3467850 $1,690,236 of the Total Offering Amount represents the aggregate exercise price for warrants to purchase shares of Series A-1 Preferred Stock pursuant to the Convertible Note and Warrant Purchase Agreement dated 4/22/09. false 41 1215000 19458 Additional commission includes warrants to purchase up to 3,808,777 shares of Series A-1 Preferred Stock at $0.10 per share. 0 false CALYPSO MEDICAL TECHNOLOGIES INC /s/Mark Querry Mark Querry Vice President, Commercial Operations 2009-09-24 -----END PRIVACY-ENHANCED MESSAGE-----